+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Alzheimer's Disease Market and Competitive Landscape - 2020

  • ID: 5023522
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Alzheimer's Disease Market and Competitive Landscape - 2020, provides comprehensive insights into the Alzheimer's Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Alzheimer's Disease market size and drug sales. It also provides insights into Alzheimer's Disease epidemiology and late stage pipeline.

This research covers the following: Alzheimer's Disease treatment options, Alzheimer's Disease late stage clinical trials pipeline, Alzheimer's Disease prevalence by countries, Alzheimer's Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Alzheimer's Disease pipeline: Find out drugs in clinical trials for the treatment of Alzheimer's Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Alzheimer's Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Alzheimer's Disease by countries
  • Alzheimer's Disease drugs: Identify key drugs marketed and prescribed for Alzheimer's Disease in the US, including trade name, molecule name, and company
  • Alzheimer's Disease drugs sales: Find out the sales value for Alzheimer's Disease drugs by countries
  • Alzheimer's Disease market valuations: Find out the market size for Alzheimer's Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Alzheimer's Disease drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Alzheimer's Disease drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Alzheimer's Disease market
  • Develop in-depth knowledge of competition and markets
  • Analyze Alzheimer's Disease drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Alzheimer's Disease market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 2
1. Alzheimer's Disease Treatment Options

2. Alzheimer's Disease Pipeline Insights
2.1. Alzheimer's Disease Phase 3 Clinical Trials
2.2. Alzheimer's Disease Phase 2 Clinical Trials
2.3. Alzheimer's Disease Phase 1 Clinical Trials

3. Alzheimer's Disease Epidemiology Analysis by Countries

4. Germany Alzheimer's Disease Market Insights
4.1. Marketed Drugs for Alzheimer's Disease in Germany
4.2. Germany Alzheimer's Disease Market Size & Forecast
4.3. Germany Alzheimer's Disease Drugs Sales Forecast
4.4. Germany Alzheimer's Disease Market Share Analysis

5. France Alzheimer's Disease Market Insights
5.1. Marketed Drugs for Alzheimer's Disease in France
5.2. France Alzheimer's Disease Market Size & Forecast
5.3. France Alzheimer's Disease Product Sales Forecast
5.4. France Alzheimer's Disease Market Share Analysis

6. Italy Alzheimer's Disease Market Insights
6.1. Marketed Drugs for Alzheimer's Disease in Italy
6.2. Italy Alzheimer's Disease Market Size & Forecast
6.3. Italy Alzheimer's Disease Product Sales Forecast
6.4. Italy Alzheimer's Disease Market Share Analysis

7. Spain Alzheimer's Disease Market Insights
7.1. Marketed Drugs for Alzheimer's Disease in Spain
7.2. Spain Alzheimer's Disease Market Size & Forecast
7.3. Spain Alzheimer's Disease Product Sales Forecast
7.4. Spain Alzheimer's Disease Market Share Analysis

8. UK Alzheimer's Disease Market Insights
8.1. Marketed Drugs for Alzheimer's Disease in UK
8.2. UK Alzheimer's Disease Market Size & Forecast
8.3. UK Alzheimer's Disease Product Sales Forecast
8.4. UK Alzheimer's Disease Market Share Analysis

9. Europe Alzheimer's Disease Market Insights
9.1. Europe Alzheimer's Disease Market Size & Forecast
9.2. Europe Alzheimer's Disease Product Sales Forecast
9.3. Europe Alzheimer's Disease Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Alzheimer's Disease Phase 3 Clinical Trials, Global, 2020
Table 2: Alzheimer's Disease Phase 2 Clinical Trials, Global, 2020
Table 3: Alzheimer's Disease Phase 1 Clinical Trials, Global, 2020
Table 4: Alzheimer's Disease Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Alzheimer's Disease in Germany, 2019
Table 6: Germany Alzheimer's Disease Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Alzheimer's Disease Product Sales ($mn), 2016 - 2024
Table 8: Germany Alzheimer's Disease Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Alzheimer's Disease in France, 2019
Table 10: France Alzheimer's Disease Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Alzheimer's Disease Product Sales ($mn), 2016 - 2024
Table 12: France Alzheimer's Disease Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Alzheimer's Disease in Italy, 2019
Table 14: Italy Alzheimer's Disease Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Alzheimer's Disease Product Sales ($mn), 2016 - 2024
Table 16: Italy Alzheimer's Disease Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Alzheimer's Disease in Spain, 2019
Table 18: Spain Alzheimer's Disease Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Alzheimer's Disease Product Sales ($mn), 2016 - 2024
Table 20: Spain Alzheimer's Disease Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Alzheimer's Disease in UK, 2019
Table 22: UK Alzheimer's Disease Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Alzheimer's Disease Product Sales ($mn), 2016 - 2024
Table 24: UK Alzheimer's Disease Market Events and Trends, 2016 - 2024
Table 25: Europe Alzheimer's Disease Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Alzheimer's Disease Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Alzheimer's Disease Pipeline by Phase (%), Global, 2020
Figure 2: Alzheimer's Disease Prevalence by Countries, 2016 - 2024
Figure 3: Germany Alzheimer's Disease Market Size ($mn), 2016 - 2024
Figure 4: Germany Alzheimer's Disease Product Sales ($mn), 2016 - 2024
Figure 5: Germany Alzheimer's Disease Market Share by Drugs (%), 2019
Figure 6: Germany Alzheimer's Disease Market - Future Market Share (%), 2024
Figure 7: France Alzheimer's Disease Market Size ($mn), 2016 - 2024
Figure 8: France Alzheimer's Disease Product Sales ($mn), 2016 - 2024
Figure 9: France Alzheimer's Disease Market Share by Drugs (%), 2019
Figure 10: France Alzheimer's Disease Market - Future Market Share (%), 2024
Figure 11: Italy Alzheimer's Disease Market Size ($mn), 2016 - 2024
Figure 12: Italy Alzheimer's Disease Product Sales ($mn), 2016 - 2024
Figure 13: Italy Alzheimer's Disease Market Share by Drugs (%), 2019
Figure 14: Italy Alzheimer's Disease Market - Future Market Share (%), 2024
Figure 15: Spain Alzheimer's Disease Market Size ($mn), 2016 - 2024
Figure 16: Spain Alzheimer's Disease Product Sales ($mn), 2016 - 2024
Figure 17: Spain Alzheimer's Disease Market Share by Drugs (%), 2019
Figure 18: Spain Alzheimer's Disease Market - Future Market Share (%), 2024
Figure 19: UK Alzheimer's Disease Market Size ($mn), 2016 - 2024
Figure 20: UK Alzheimer's Disease Product Sales ($mn), 2016 - 2024
Figure 21: UK Alzheimer's Disease Market Share by Drugs (%), 2019
Figure 22: UK Alzheimer's Disease Market - Future Market Share (%), 2024
Figure 23: Europe Alzheimer's Disease Market Size ($mn), 2016 - 2024
Figure 24: Europe Alzheimer's Disease Product Sales ($mn), 2016 - 2024
Figure 25: Europe Alzheimer's Disease Market Share by Drugs (%), 2019
Figure 26: Europe Alzheimer's Disease Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
Adroll
adroll